These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15001195)

  • 1. Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration.
    Manzella D; Grella R; Esposito K; Giugliano D; Barbagallo M; Paolisso G
    Am J Hypertens; 2004 Mar; 17(3):223-7. PubMed ID: 15001195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control.
    Manzella D; Barbieri M; Rizzo MR; Ragno E; Passariello N; Gambardella A; Marfella R; Giugliano D; Paolisso G
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2769-74. PubMed ID: 11397885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.
    Abbasi F; Chu JW; McLaughlin T; Lamendola C; Leary ET; Reaven GM
    Metabolism; 2004 Feb; 53(2):159-64. PubMed ID: 14767866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
    Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
    Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes.
    Roach P; Malone JK
    Diabet Med; 2006 Jul; 23(7):743-9. PubMed ID: 16842478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients.
    Negro R; Mangieri T; Dazzi D; Pezzarossa A; Hassan H
    Diabetes Res Clin Pract; 2005 Oct; 70(1):20-5. PubMed ID: 16126119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
    Abbasi F; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucose ingestion on cardiac autonomic nervous system in healthy centenarians: differences with aged subjects.
    Paolisso G; Manzella D; Rizzo MR; Barbieri M; Gambardella A; Varricchio M
    Eur J Clin Invest; 2000 Apr; 30(4):277-84. PubMed ID: 10759874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study.
    Gregorio F; Ambrosi F; Manfrini S; Santucci A; Filipponi P
    Diabetes Res Clin Pract; 1997 Jul; 37(1):21-33. PubMed ID: 9279474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.
    Jones TA; Sautter M; Van Gaal LF; Jones NP
    Diabetes Obes Metab; 2003 May; 5(3):163-70. PubMed ID: 12681023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
    Sathyanarayana P; Jogi M; Muthupillai R; Krishnamurthy R; Samson SL; Bajaj M
    Obesity (Silver Spring); 2011 Dec; 19(12):2310-5. PubMed ID: 21660077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training improves cardiovascular autonomic modulation in response to glucose ingestion in obese adults with and without type 2 diabetes mellitus.
    Goulopoulou S; Baynard T; Franklin RM; Fernhall B; Carhart R; Weinstock R; Kanaley JA
    Metabolism; 2010 Jun; 59(6):901-10. PubMed ID: 20015524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A; Schmülling RM; Häring HU; Stumvoll M
    Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.